William J. Chase
Independent DirectorMr. William J. Chase, also known as Bill, MBA, is Independent Director of GRAIL, Inc. from June 11, 2024. He is Independent Director of Intellia Therapeutics, Inc. from April 14, 2023. He served as an Executive Vice President of Finance and Administration at AbbVie Inc. since October 19, 2018 until July 2019. He has been an Independent Director of PAREXEL International Corporation since November 2021. Previously, he served as the Chief Financial Officer and Executive Vice President at AbbVie Inc. until October 19, 2018. Mr. Chase served as a Vice President of Licensing & Acquisitions at Abbott Laboratories. Mr. Chase served more than 20 years in various capacities at Abbott, including as Vice President of Licensing & Acquisitions since 2010 and as its Treasurer. He also serves as the Director of AbbVie Private Limited. Mr. Chase holds a Bachelor of Science Degree in finance from the University of Illinois and a Master of Business Administration from the University of Chicago Booth School of Business.
Positions
- Company NameGRAIL, Inc.Stock CodeGRALPositionIndependent DirectorColleagues
- JJJoshua J. OfmanCEO & Director
- GLGregory L. SummeIndependent Chairman of the Board
- AFAaron FreidinCFO & Head of Corporate Development
- RPRobert P. RagusaAdvisor
- PCPaul CiccolellaSenior Vice President of Global Development & Operations
- SASatnam AlagChief Technology Officer
- SCSteven C. MizellIndependent Director
- SKSarah KrevansIndependent Director
